公司資料
Organovo Holdings 股價、新聞與催化劑
- 股票代碼:
- ONVO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for ONVO.
公司概覽
業務概覽
Organovo Holdings is a biotechnology company historically focused on 3D bioprinting and tissue-engineering concepts. Its story has been tied to tissue fabrication and the long-term promise of regenerative biology.
所在地與產業分類
Organovo is headquartered in the United States and listed on NASDAQ. It sits in regenerative biotechnology and platform science.
商業模式特徵
The company depends on scientific validation, strategic focus, and the ability to convert tissue-engineering ideas into a viable business. Investors historically watched platform shifts and capital runway.
生技產業定位
Organovo belongs to the historical regenerative-platform bucket. It has been a long-dated science story where commercialization has been difficult to sustain.
未來催化劑
- Organovo is now largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live tissue-engineering milestone. The market is focused on residual value.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。